| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biomedical Division, The Samuel Roberts Noble Foundation, Inc., Box 2180, Ardmore, Oklahoma 73402
Two human erythroleukemia cell lines, HEL and K562, express transglutaminase activity. The enzyme was identified as a tissue transglutaminase following chromatographic purification. All-trans-retinoic acid (10 µM) stimulated differentiation in HEL cells as judged by a 4-fold increase in hemoglobin content and a reduction in cell proliferation. The transglutaminase activity increased 9-fold. This increase in transglutaminase was the result of a pretranslational regulation of the gene as revealed by Northern blot analysis of mRNA. These changes were not a result of cell apoptosis, since parallel DNA degradation catalyzed by a Ca2+-dependent endonuclease could not be demonstrated. The K562 cells, in contrast, showed no transglutaminase induction following exposure to retinoic acid and displayed no changes in maturation markers or cell growth.
Received 3/26/90. Accepted 9/10/90.
This article has been cited by other articles:
![]() |
S.-A. Jung, H. K. Lee, J. S. Yoon, S.-J. Kim, C. Y. Kim, H. Song, K.-C. Hwang, J. B. Lee, and J. H. Lee Upregulation of TGF-{beta}-Induced Tissue Transglutaminase Expression by PI3K-Akt Pathway Activation in Human Subconjunctival Fibroblasts Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 1952 - 1958. [Abstract] [Full Text] [PDF] |
||||
![]() |
X H Wan, E H Lee, H J Koh, J Song, E K Kim, C Y Kim, J B Lee, S-Y Kim, K Yao, and J H Lee Enhanced expression of transglutaminase 2 in anterior polar cataracts and its induction by TGF-{beta} in vitro Br. J. Ophthalmol., November 1, 2002; 86(11): 1293 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Boehm, U. Singh, C. Combs, M. A. Antonyak, and R. A. Cerione Tissue Transglutaminase Protects against Apoptosis by Modifying the Tumor Suppressor Protein p110 Rb J. Biol. Chem., May 31, 2002; 277(23): 20127 - 20130. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu, R. A. Cerione, and J. Clardy Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity PNAS, February 20, 2002; (2002) 42454899. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Joseph, O. Lefebvre, C. Mereau-Richard, P.-M. Danze, M.-T. Belin-Plancot, and P. Formstecher Evidence for the Involvement of Both Retinoic Acid Receptor- and Retinoic X Receptor-Dependent Signaling Pathways in the Induction of Tissue Transglutaminase and Apoptosis in the Human Myeloma Cell Line RPMI 8226 Blood, April 1, 1998; 91(7): 2423 - 2432. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu, R. A. Cerione, and J. Clardy Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity PNAS, March 5, 2002; 99(5): 2743 - 2747. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |